[HTML][HTML] Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
N Balmaceda, M Aziz, VT Chandrasekar, B McClune… - BMC cancer, 2021 - Springer
Background Patients with multiple myeloma (MM) remain at an increased risk of infection
due to the disease process, as well as the ensuing treatments. Methods We performed a …
due to the disease process, as well as the ensuing treatments. Methods We performed a …
Infection risks in multiple myeloma: A systematic review and meta-analysis of randomized trials from 2015 to 2019
N Balmaceda, M Aziz, VT Chandrasekar, B McClune… - 2021 - kuscholarworks.ku.edu
Background Patients with multiple myeloma (MM) remain at an increased risk of infection
due to the disease process, as well as the ensuing treatments. Methods We performed a …
due to the disease process, as well as the ensuing treatments. Methods We performed a …
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
N Balmaceda, M Aziz, VT Chandrasekar… - BMC …, 2021 - mdanderson.elsevierpure.com
Background: Patients with multiple myeloma (MM) remain at an increased risk of infection
due to the disease process, as well as the ensuing treatments. Methods: We performed a …
due to the disease process, as well as the ensuing treatments. Methods: We performed a …
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
N Balmaceda, M Aziz, VT Chandrasekar… - BMC …, 2021 - search.proquest.com
Background Patients with multiple myeloma (MM) remain at an increased risk of infection
due to the disease process, as well as the ensuing treatments. Methods We performed a …
due to the disease process, as well as the ensuing treatments. Methods We performed a …
[HTML][HTML] Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
N Balmaceda, M Aziz, VT Chandrasekar, B McClune… - BMC Cancer, 2021 - ncbi.nlm.nih.gov
Background Patients with multiple myeloma (MM) remain at an increased risk of infection
due to the disease process, as well as the ensuing treatments. Methods We performed a …
due to the disease process, as well as the ensuing treatments. Methods We performed a …
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
N Balmaceda, M Aziz, VT Chandrasekar… - BMC …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Patients with multiple myeloma (MM) remain at an increased risk of infection
due to the disease process, as well as the ensuing treatments. Methods We performed a …
due to the disease process, as well as the ensuing treatments. Methods We performed a …
[PDF][PDF] Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
N Balmaceda, M Aziz, VT Chandrasekar, B McClune… - 2021 - scholar.archive.org
Background: Patients with multiple myeloma (MM) remain at an increased risk of infection
due to the disease process, as well as the ensuing treatments. Methods: We performed a …
due to the disease process, as well as the ensuing treatments. Methods: We performed a …
[HTML][HTML] Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
N Balmaceda, M Aziz, VT Chandrasekar… - BMC …, 2021 - bmccancer.biomedcentral.com
Patients with multiple myeloma (MM) remain at an increased risk of infection due to the
disease process, as well as the ensuing treatments. We performed a systematic review to …
disease process, as well as the ensuing treatments. We performed a systematic review to …
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019.
N Balmaceda, M Aziz, VT Chandrasekar, B McClune… - BMC Cancer, 2021 - europepmc.org
Background Patients with multiple myeloma (MM) remain at an increased risk of infection
due to the disease process, as well as the ensuing treatments. Methods We performed a …
due to the disease process, as well as the ensuing treatments. Methods We performed a …
[PDF][PDF] Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
N Balmaceda, M Aziz, VT Chandrasekar, B McClune… - 2021 - researchgate.net
Background: Patients with multiple myeloma (MM) remain at an increased risk of infection
due to the disease process, as well as the ensuing treatments. Methods: We performed a …
due to the disease process, as well as the ensuing treatments. Methods: We performed a …